Analysen von Richard Vosser
| 08.09.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.09.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 31.08.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 31.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 30.08.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 29.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 25.08.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 12.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 09.08.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 05.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.08.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.07.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.07.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 25.07.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 25.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 22.07.22 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 21.07.22 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 21.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 21.07.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 20.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.07.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 19.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.07.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 18.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 15.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 04.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 04.07.22 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 30.06.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 30.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 29.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.06.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 07.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 07.06.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 06.06.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 27.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 16.05.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 12.05.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 11.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.05.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 10.05.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.05.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.05.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.05.22 | Sanofi Overweight | JP Morgan Chase & Co. | |